Sechenov School
Home › Biochemistry › Sickle Cell Anemia

Sickle Cell Anemia

For medical students2 min readUpdated 2026-10-10

Sickle cell anemia is a genetic disorder caused by the formation of abnormal hemoglobin S (HbS). Due to a point mutation, the protein loses its solubility in deoxygenated blood, deforming erythrocytes into sickle shapes, leading to premature destruction (hemolysis) and tissue hypoxia.

Defect LocationN-terminal region of the hemoglobin $\beta$-chain (6th position)
Mutation TypeSubstitution of glutamic acid with valine
Aggregation ConditionLow oxygen partial pressure (oxygen unloading in tissues)
Key ConsequencesSplenic hemolysis, capillary thrombosis, and tissue hypoxia

Biochemical Basis of the Disease

Normal adult hemoglobin (HbA) efficiently performs its primary function: transporting oxygen to tissues. However, in sickle cell anemia, an abnormal hemoglobin variant—HbS—is synthesized.

The core of the problem lies in the primary structure of the protein, specifically a point mutation in the N-terminal region of the $\beta$-chain. Comparing the first eight amino acids in both molecules reveals complete identity at positions 1–5 and 7–8 (Val–His–Leu–Thr–Pro–...–Glu–Lys). The single, fatal difference occurs at the 6th position:

To understand the magnitude of this consequence, one must look at the chemical properties of these two amino acids. Glutamic acid is a polar, negatively charged (acidic), and strongly hydrophilic molecule that interacts favorably with aqueous environments. Valine, conversely, is non-polar, uncharged, and completely hydrophobic (water-fearing).

Mechanism of Polymerization: The "Sticky" Patch

The substitution of a hydrophilic residue with a hydrophobic one occurs directly on the surface of the protein globule. As a result, a specific hydrophobic patch is exposed on the hemoglobin molecule, acting as a "sticky" site.

As long as blood is oxygenated, this defect may remain clinically silent. However, once an erythrocyte enters tissues with low oxygen partial pressure (venous blood), hemoglobin shifts to its deoxygenated state. Under these conditions, HbS molecules attempt to shield their hydrophobic patches from water and begin to aggregate via hydrophobic interactions.

Protein solubility drops sharply. The molecules assemble into long, rigid polymer fibers that ultimately precipitate within the cell.

Pathogenesis: From Molecule to Tissue Hypoxia

The formation of protein polymers inevitably impacts the cellular level. An erythrocyte packed with insoluble HbS fibers loses its elasticity and normal biconcave shape, transforming into a rigid "sickle."

The subsequent pathogenic cascade proceeds as follows:

  1. Deformation. Shape changes render erythrocytes fragile and unable to squeeze through narrow blood vessels.
  2. Capillary Occlusion. Rigid sickle cells become trapped in the microvasculature.
  3. Hemolysis. Defective erythrocytes undergo accelerated destruction during passage through the spleen, leading to marked anemia.
  4. Outcome. Due to reduced oxygen carrier capacity and impaired microcirculation, a critical systemic problem develops: tissue hypoxia.

Mnemonic

Remember VALine over GLUtamic acid: in normal HbA, position 6 has GLUtamic acid (soluble, hydrophilic), but in HbS, it gets replaced by VALine (hydrophobic, causing molecules to aggregate and 'stick' like a valenki winter boot).

Frequently asked questions

Which laboratory diagnostic methods are used to detect abnormal hemoglobin S?

Screening laboratory diagnostics include:

  • Capillary electrophoresis.
  • High-performance liquid chromatography (HPLC).

Suspected sickle cell disease is indicated by elevated fetal hemoglobin (HbF) and the detection of abnormal hemoglobin fractions, including HbS, HbC, HbD, or HbO.

What is the primary structural mutation in the hemoglobin beta-chain in sickle cell disease?

A point mutation at the 6th position of the $\beta$-chain replaces the hydrophilic glutamic acid with hydrophobic valine.

Why do HbS molecules form polymer fibers?

The presence of valine exposes a hydrophobic 'sticky' patch on the protein surface. Under hypoxic conditions, molecules aggregate via hydrophobic interactions.

Under what conditions do erythrocytes assume a sickle shape?

This occurs in the venous circulation where oxygen partial pressure is low. Upon releasing oxygen, deoxygenated HbS loses solubility and precipitates, deforming the cell.

What is the ultimate pathological outcome for tissues in this disease?

Erythrocyte destruction and capillary occlusion impair oxygen delivery, culminating in tissue hypoxia.

Go deeper

More topics in Biochemistry

Glycogen Storage Diseases: Types, Pathogenesis and Clinical FeaturesEicosanoids: Synthesis, Pathways, and PharmacologyUrea CycleCorticosteroidsPyrimidine Nucleotide SynthesisLamininGenetic CodeMAPK CascadeOxidative Decarboxylation of PyruvateDiabetes Mellitus and Alpha-Glucosidase InhibitorsCholesterol MetabolismFolic Acid MetabolismBiochemistry →